Emerging Echinocandin Resistance – A Review
Author(s) -
P. Sneka,
Krishnan Mahalakshmi,
V. Sangamithra
Publication year - 2021
Publication title -
journal of pharmaceutical research international
Language(s) - English
Resource type - Journals
ISSN - 2456-9119
DOI - 10.9734/jpri/2021/v33i53a33639
Subject(s) - echinocandin , echinocandins , antifungal , medicine , intensive care medicine , drug resistance , candida infections , microbiology and biotechnology , biology , fluconazole , dermatology , caspofungin
Worldwide there is a steady increase in the number of fungal infections each year. Simultaneously, there is a high rise of antifungal resistance among the Candida isolates. This has now become a major concern in hospitalized patients resulting in poor treatment outcome. Echinocandins, a new group of antifungals has given promising results inspite of its increasing rate of resistance exhibited by some Candida species.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom